As previously outlined, since TREM-1 overexpression in the gut occurs only in pathological conditions, the involvement of this receptor in cancer onset is just secondary to inflammation, with resistance to cell death and induction of angiogenesis. This evidence concerns the gene TREM1 and cancer.